Tokyo, June 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062061) titled 'Study of the Spatial Extent of Changes in Pain Sensitivity Following Trigger Point Acupuncture Stimulation' on June 26.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control

Primary Sponsor: Institute - Kansai University of Health Sciences

Condition: Condition - Chronic Low Back Pain Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The purpose of this study is to quantitatively evaluate the spatial extent of the reduction in peripheral sensitization induced by trigger point acupuncture using pressure pain thresholds. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Acupuncture stimulation will be applied to a trigger point at which symptom reproduction is confirmed by manual compression. After needle insertion, the needle will be retained in situ for 10 minutes without additional manual stimulation and then removed.

Eligibility: Age-lower limit - 18 years-old = Gender - Male and Female Key inclusion criteria - Adults aged 18~65 years. Students or employees of the university. Individuals with chronic low back pain lasting for at least 3 months. No history of lumbar spine surgery. No symptoms suggestive of lower extremity radiculopathy. Reproduction of their usual low back pain upon manual compression of the lumbar multifidus muscle, including the area approximately 2 cm lateral to the midline at the L4 vertebral level. Ability to reliably report symptom reproduction during acupuncture stimulation. Previous experience with acupuncture treatment. Provision of written informed consent. Key exclusion criteria - Individuals with severe fear of acupuncture treatment. Individuals who have previously experienced all acupuncture stimulation as strongly unpleasant or painful sensations. Pregnant women or individuals who may be pregnant. Individuals with bleeding disorders or those receiving anticoagulant therapy. Individuals with severe orthopedic, neurological, or psychiatric disorders. Individuals deemed unsuitable for study participation by the principal investigator. Target Size - 30

Recruitment Status: Recruitment status - Enrolling by invitation Date of protocol fixation - 2025 Year 08 Month 26 Day Date of IRB - 2025 Year 08 Month 26 Day Anticipated trial start date - 2025 Year 08 Month 26 Day Last follow-up date - 2027 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071013

Disclaimer: Curated by HT Syndication.